IncFact
Company Profiles: Revenue, Growth, Competition

Amicus Therapeutics US Revenue, Growth & Competitor Profile

DBA AMICUS THERAPEUTICS, INC.
Last updated:

Company Awards

 
Public Company
public company
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Amicus Therapeutics US

Access the complete profile.

Amicus Therapeutics US Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
Address3675 Market Street
Philadelphia, PA 19104

Note: Revenues for privately held companies are statistical evaluations.


Amicus Therapeutics US's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Amicus Therapeutics US is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Amicus Therapeutics US Annual Revenue and Growth Rate

Amicus Therapeutics US Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $10 - $100 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Amicus Therapeutics US's revenues are gauged from an analysis of company filings.



Amicus Therapeutics US's Income Statement (based on Industry Averages)

Amicus Therapeutics US P&L$ Millions
Revenue (Sales) Amicus Therapeutics US Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Amicus Therapeutics US is developing and marketing. Amicus Therapeutics US's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
IN THE FIGHT TO REMAIN AT THE FOREFRONT OF THERAPIES FOR RARE AND ORPHAN DISEASES
Providing medical services for the treatment of rare genetic diseases; Providing health information in the field of rare genetic diseases; Providing medical information in the field of rare genetic diseases
03/31/2023
MYDAY POMPE
Downloadable computer application software for mobile devices, namely, software for Pompe disease patients to administer and comply with their dosing regimen
05/06/2022
CARITAS THERAPEUTICS
Pharmaceutical preparations for treatment of rare diseases
09/03/2021

See all trademarks and details in the Full Report.


Market Share of Amicus Therapeutics US's Largest Competitors

A competitive analysis shows these companies are in the same general field as Amicus Therapeutics US, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSDenver, CO100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM30 
INC RESEARCHRaleigh, NC27 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
SYNEOS HEALTHRaleigh, NC13 
ILLUMINASan Diego, CA12 
UT-BATTELLEOak Ridge, TN11 
PRA HOLDINGSRaleigh, NC11 




Nearby Competitors

These companies are similar in business line and location to Amicus Therapeutics US. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
WISTAR INSTITUTE OF ANATOMY & BIOLOGYPhiladelphia, PA100 
CENTURY THERAPEUTICSPhiladelphia, PA94 
AMICUS THERAPEUTICS USPhiladelphia, PA83 
AMERICAN ASSN FOR CANCER RESPhiladelphia, PA72 
CARISMA THERAPEUTICSPhiladelphia, PA51 
INTERIUS BIOTHERAPEUTICSPhiladelphia, PA38 




Future Competition: Amicus Therapeutics US's Fastest Growing Competitors

These companies are in the same general field as Amicus Therapeutics US and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Amicus Therapeutics US Competitors